openPR Logo
Press release

Lipid Panel Test Market Estimated to Flourish by 2015 – 2023

04-17-2018 08:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Lipid Panel Test Market Estimated to Flourish by 2015 – 2023

Lipid Panel Test Market: Overview

Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal’s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5813

Moreover, other tests can also be deployed in addition for a CHD risk factor analysis such as apolipoprotein B (apo B) test. Apo B is a protein molecule, which primarily constitutes lipoproteins like VLDL & LDL.  Apo B test is usually conducted under special circumstances along with an Apo A and routine lipid profile, which determines an individual’s risk of developing CHD, in cases where there is a family history of CHDs along with elevated triglyceride levels due to overactive lipid metabolism. The concentration of Apo A-I is directly proportional to HDL levels and is found to have a strong correlation with CHD.LPT also provides the ratio among different values for TC to HDL-C (TC/HDL-C) and the ratio of LDL-C to HDL-C (LDL-C/HDL-C) which can be used as markers for a risk factor analysis.

The evidence in favor of potential growth in the LPT market can be related with two main factors. First, screening and identification of population with moderate to high risk and for their follow up in later stages. The second factor would be LPT routine testing for monitoring clinical and subclinical cases of lipid disorders. Lipid disorder is one of the risk factors for CHD, necessitating prompt diagnosis through LPT among those who have family history of CHD. Moreover, middle age group men and women collectively form the moderate to high-risk population. Thus, LPT market has a tremendous scope if used as a screening tool for rapid diagnosis of lipid and its associated disorders due to rising disease burden. This epidemiologic transition is evident from the prevalence rate of diet-related chronic diseases, which have become the major killers.

Request to View TOC of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=5813

The lipid panel test market can be segmented based on its application into disease segments, hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hyperlipoproteinemia, and tangier disease. End users include home based testing kits, diagnostic laboratories, hospitals, and others (CROs, Public Health Institutions).

The potential drivers in the market include higher funding from government and global healthcare institutions such as the World Health Organisation (WHO) for screening programs to identify at-risk population and dyslipidemia diagnosis. The other demand side factors include high prevalence of dyslipidemia, cardiovascular diseases, and hypertension. However, some of the restraints are attributed to healthcare reforms such as the Affordable Health Care for America Act, which will curb high healthcare costs, reducing the profit margins for those operating in the industry. Moreover, there are global initiatives to curb out-of-pocket health expenditure for chronic diseases. Similarly, future prospects for growth in Germany remains blunt due to cost cutting strategies in their public insurance program for clinical testing or pathology payments.

Some of the major players in the lipid panel test market include Abbott Laboratories, Alere Inc., Avanti Polar Lipids, Inc., Beckman Coulter, Inc., EuroMedixPOC nv/sa, F. Hoffmann-La Roche Ltd, PTS Diagnostics, Quest Diagnostics, Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.

Request For Discount On This Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=5813

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lipid Panel Test Market Estimated to Flourish by 2015 – 2023 here

News-ID: 1020389 • Views: 244

More Releases from Transparency Market Research

Cancer Registry Software Market Analysis Industry 2027 | Elekta AB, Rocky Mounta …
Global Cancer Registry Software Market: Overview Cancer registry is an information system or computerized database to maintain and collect the data related to cancer patients. This data helps in the evaluation of trends and ultimately enhances the cancer patient care. According to the World Health Organization, cancer killed about 9.6 million people in 2018. This explains the need for a cancer registry software and has facilitated the expansion of the
Biopharmaceutical CMO & CRO Market By Leading Manufacturers, Demand and Growth O …
Global Biopharmaceutical CMO & CRO Market: Overview Huge investments made in biopharmaceutical industry by the key players with the aim to improve their productivity and efficiency. This factor has forced the biomanufacturers to increase their focus on outsourcing activities. Mergers and acquisition plays an important role in and helps CMOs by integrating bioprocessing services to their clients. This, in turn, makes CROs/CMOs better opportunity for product launch.
Smart Stethoscopes Market Growth Probability, Key Vendors and Future Scenario Up …
The first stethoscope was introduced in the market in 1818 by a French physician René Laennec. Since then, there have been huge advancements in the field of cardiac imaging and radiology. Cardiovascular diseases are still the major cause of death in the world, and early diagnosis is quintessential to save lives. A vast number of noninvasive investigational modalities exist for early diagnosis of cardiac disorders, such as cardiac computed tomographic
Medical Drones Market Key Players' Profile and Industry Analysis to 2025 - DJI, …
Global Medical Drones Market: Introduction Medical Drones industry can be followed back to late 1800 and mid 1900 for military activities. At first drones were utilized to keep an eye on nations during cold war. The principal target drone was created somewhere around 1933 and 1935 at RAF Farnborough by consolidating fuselage with engine and wings. Report Overview @ https://www.transparencymarketresearch.com/medical-drones-market.html Drones were likewise utilized in combat zone surveillance, anti-submarine warfare, and target practice. Uses

All 5 Releases


More Releases for Lipid

Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Coated Bead Products - Exclusive Tools From Echelon for Protein-Lipid Inte …
MoBiTec's partner company Echelon Biosciences, USA, is excited to introduce a new class of lipid microparticles small enough to be used in phagocytosis experiments! Phosphatidylserine (PS), Phosphatidylcholine (PC), and PC/PS microparticles have phospholipids attached in a unique way allowing headgroups to be exposed and available for the study of biological interactions. Their size, approximately 3 µm, are ideal for phagocytosis and accommodates analysis with standard flow cytometry and microscopy methods. Lipid
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Nutrition Market Growth with Worldwide Industry Analysis to 2025
Lipid Nutrition Market: Introduction: Lipid Nutrition is essential to fast required in our daily diet for proper functionality and metabolism of our body. The lipid nutrition market is composed of different types of fats with specific functionality and benefits of the human body. Also, lipid nutrition is also used in animal feed and pet food formulas to increase lipid contain the by products from the livestock and increase pet health. The
Asia-Pacific Lipid Market will Target Emerging Markets by 2022
In this report, the Asia-Pacific Lipid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Lipid for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast
Lipid Panel Test Market : Industry Perspective And Comprehensive Analysis 2023
Lipid panel test (LPT) or total lipid profile enables diagnosis of lipid disorders along with risk for CHDs. There is a high correlation between coronary heart diseases (CHD) with abnormal lipid levels. The test provides value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL.LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. Obtain Report Details @ http://www.transparencymarketresearch.com/lipid-panel-test-market.html Moreover,